{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:07:30Z","timestamp":1765976850598,"version":"3.41.2"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Lifestyle modifications, particularly the adoption of healthy dietary patterns such as the Mediterranean Diet (MedDiet), are foundational in any treatment plan, including for patients prescribed first-line statin therapy for hypercholesterolemia. However, the rising popularity of MedDiet-associated foods and nutraceuticals among health-conscious consumers has raised concerns about their potential interactions with statins, potentially leading to adverse effects. One notable example involves polyphenol supplements, a class of anti-dyslipidemic phytochemicals known to influence statins\u2019 pharmacokinetics. Still, whether chronic polyphenol exposure achieves plasma concentrations sufficient to alter statin pharmacokinetics in clinical settings is controverse. Moreover, it remains unclear which key biological targets are shared by both classes of molecules and how they mediate potential pharmacokinetic and pharmacodynamic interactions. This study aims to systematically map reported statin-polyphenol interactions and identify the principal biological targets involved, elucidating their impact on statin pharmacokinetics, efficacy, and toxicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A scoping review was conducted using the PubMed\/Medline, Scopus, and Web of Science databases. This work was designed in accordance with PRISMA-ScR. The review protocol was registered in the Open Science Framework.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Statin-polyphenol interactions were reported in 83.9% of the studies analyzed. The biological targets mediating these interactions play chief roles in statins\u2019 cellular uptake (OATP\/P-glycoprotein), metabolism (CYP450\/intestinal esterases), and core mechanisms underlying statin action, namely, HMG-CoA reductase inhibition. Polyphenols significantly influenced statin pharmacokinetics, altering total drug exposure (AUC) and extent (Cmax), either by enhancement or inhibition, with apparently less impact on statins\u2019 absorption rate (Tmax). At the clinical level, only five studies addressed statin-polyphenol interactions, yielding conflicting results on the potential enhancement of therapeutic efficacy and adverse effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This work presents an integrated perspective on the cellular and molecular mechanisms underlying statin\u2013polyphenol interactions. It highlights substantial inter-individual variability linked to conflicting evidence, from synergistic effects enabling lower statin doses and reduced adverse events to potential exacerbation of side effects. These findings underscore the need for controlled studies to clarify the clinical relevance of polyphenol-induced alterations in statin pharmacokinetics and pharmacodynamics. Such data are essential to develop evidence-based guidelines that may optimize statin therapy and support individualized treatment strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>identifier 10.17605\/OSF.IO\/DJW5G.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1541871","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:47:30Z","timestamp":1748584050000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Lipid-lowering statins and polyphenol-based supplementation: a scoping review on drug-food interaction potential"],"prefix":"10.3389","volume":"16","author":[{"given":"Rita","family":"Costa","sequence":"first","affiliation":[]},{"given":"Carolina","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Fl\u00e1vio","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Malva","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Viana","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1080\/10942912.2016.1220393","article-title":"Natural polyphenols: an overview","volume":"20","author":"Abbas","year":"2017","journal-title":"Int. J. Food Prop."},{"key":"B2","doi-asserted-by":"publisher","first-page":"6276438","DOI":"10.1155\/2018\/6276438","article-title":"Alleviation of drugs and chemicals toxicity: biomedical value of antioxidants","volume":"2018","author":"Abdel-Daim","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s13318-020-00608-6","article-title":"Effects of green tea extract on atorvastatin pharmacokinetics in healthy volunteers","volume":"45","author":"Abdelkawy","year":"2020","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/antiox12020416","article-title":"Insights on dietary polyphenols as agents against metabolic disorders: obesity as a target disease","volume":"12","author":"Aloo","year":"2023","journal-title":"Antioxidants"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8364","DOI":"10.3390\/ijms23158364","article-title":"Statins neuromuscular adverse effects","volume":"23","author":"Attardo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3390\/foods10112595","article-title":"Polyphenols: from theory to practice","volume":"10","author":"Bertelli","year":"2021","journal-title":"Foods"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/nu10101523","article-title":"Relationship between mediterranean dietary polyphenol intake and obesity","volume":"10","author":"Castro-Barquero","year":"2018","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ejps.2009.09.018","article-title":"Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs","volume":"38","author":"Cermak","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.chemphyslip.2017.03.001","article-title":"Dietary phytochemicals in the protection against oxysterol-induced damage","volume":"207","author":"Cilla","year":"2017","journal-title":"Chem. Phys. Lipids"},{"key":"B10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clinbiochem.2018.10.007","article-title":"Weight loss achieved by bariatric surgery modifies high-density lipoprotein subfractions and low-density lipoprotein oxidation towards atheroprotection","volume":"63","author":"Coimbra","year":"2019","journal-title":"Clin. Biochem."},{"key":"B11","unstructured":"Australia \u201cCovidence systematic review software\u201d\n          \n          \n          2025"},{"key":"B12","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1194\/jlr.M011817","article-title":"Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase","volume":"52","author":"Cuccioloni","year":"2011","journal-title":"J. Lipid Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s11095-007-9492-0","article-title":"Effect of silymarin supplement on the pharmacokinetics of rosuvastatin","volume":"25","author":"Deng","year":"2008","journal-title":"Pharm. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S895","DOI":"10.4103\/0973-1296.224342","article-title":"Studying the inhibitory effect of quercetin and thymoquinone on human cytochrome P450 enzyme activities","volume":"13","author":"Elbarbry","year":"2018","journal-title":"Pharmacogn. Mag."},{"key":"B15","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.clpt.6100318","article-title":"The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1","volume":"83","author":"Fan","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1360065","DOI":"10.3389\/fimmu.2024.1360065","article-title":"Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases","volume":"15","author":"Ferreira","year":"2024","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1358\/mf.2003.25.6.769652","article-title":"Clinical pharmacokinetics of statins","volume":"25","author":"Garc\u00eda","year":"2003","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/ajhp\/52.15.1639","article-title":"Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors","volume":"52","author":"Garnett","year":"1995","journal-title":"Am. J. Health-System Pharm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/diagnostics10070483","article-title":"Cardiovascular risk and statin therapy considerations in women","volume":"10","author":"Gheorghe","year":"2020","journal-title":"Diagnostics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/s0165-6147(97)01147-4","article-title":"Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors","volume":"19","author":"Hamelin","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"37161","DOI":"10.1074\/jbc.274.52.37161","article-title":"A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters","volume":"274","author":"Hsiang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/jaocint\/qsz018","article-title":"Phenols, flavors, and the mediterranean diet","volume":"103","author":"Issaoui","year":"2020","journal-title":"J. AOAC Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0042-118170","article-title":"Impact of the herbal breviscapine on the pharmacokinetics of simvastatin in rats: the involvement of CYP3A4","volume":"67","author":"Ju","year":"2017","journal-title":"Drug Res. (Stuttg)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2147\/DDDT.S130050","article-title":"Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers","volume":"11","author":"Kim","year":"2017","journal-title":"Drug Des. Devel Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1124\/dmd.112.048272","article-title":"Interaction of silymarin flavonolignans with organic anion-transporting polypeptides","volume":"41","author":"Kock","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"B26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/bdd.2202","article-title":"Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity","volume":"40","author":"Kondo","year":"2019","journal-title":"Biopharm. Drug Dispos."},{"key":"B27","first-page":"1607","article-title":"Quercetin does not alter the oral bioavailability of Atorvastatin in rats","volume":"28","author":"Koritala","year":"2015","journal-title":"Pak J. Pharm. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e00370","DOI":"10.1016\/j.btre.2019.e00370","article-title":"Phenolic acids: natural versatile molecules with promising therapeutic applications","volume":"24","author":"Kumar","year":"2019","journal-title":"Biotechnol. Rep. (Amst)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.3390\/nu15245056","article-title":"Totum-070, a polyphenol-rich plant extract, prevents hypercholesterolemia in high-fat diet-fed hamsters by inhibiting intestinal cholesterol absorption","volume":"15","author":"Langhi","year":"2023","journal-title":"Nutrients"},{"key":"B30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/bf03192333","article-title":"Comparison of in vitro hepatic models for the prediction of metabolic interaction between simvastatin and naringenin","volume":"27","author":"Le Goff","year":"2002","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s0928-0987(02)00222-1","article-title":"In vitro inhibition of simvastatin metabolism, a HMG-CoA reductase inhibitor in human and rat liver by bergamottin, a component of grapefruit juice","volume":"18","author":"Le Goff-Klein","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1124\/dmd.106.013904","article-title":"Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction","volume":"35","author":"Li","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3390\/molecules24091666","article-title":"Effects of silymarin on the in vivo pharmacokinetics of simvastatin and its active metabolite in rats","volume":"24","author":"Li","year":"2019","journal-title":"Molecules"},{"key":"B34","doi-asserted-by":"publisher","first-page":"111045","DOI":"10.1016\/j.brainresbull.2024.111045","article-title":"Simvastatin alleviates glymphatic system damage via the VEGF-C\/VEGFR3\/PI3K-Akt pathway after experimental intracerebral hemorrhage","volume":"216","author":"Liao","year":"2024","journal-title":"Brain Res. Bull."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/s41598-020-58303-0","article-title":"Scutellarin inhibition of the rosuvastatin uptake in rat hepatocytes and the competition for organic anion transporting polypeptide 1B1 in HEK293T cells","volume":"10","author":"Liu","year":"","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11095-020-02950-5","article-title":"Scutellarin is highly likely to be responsible for drug-drug interactions mediated by hepatic organic anion-transporting Polypeptide1B3","volume":"37","author":"Liu","year":"","journal-title":"Pharm. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/gerona\/glu228","article-title":"Associations between thrombin generation and the risk of cardiovascular disease in elderly patients: results from the PROSPER study","volume":"70","author":"Loeffen","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1158\/1078-0432.CCR-07-1860","article-title":"Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin","volume":"14","author":"Lu","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s13318-013-0166-5","article-title":"Effects of silymarin on the pharmacokinetics of atorvastatin in diabetic rats","volume":"39","author":"Malekinejad","year":"2014","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejps.2012.02.014","article-title":"Inhibition of hepatic uptake transporters by flavonoids","volume":"46","author":"Mandery","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1080\/13880209.2021.1942927","article-title":"Baicalein inhibits the pharmacokinetics of simvastatin in rats via regulating the activity of CYP3A4","volume":"59","author":"Meng","year":"2021","journal-title":"Pharm. Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00228-018-2420-x","article-title":"Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers","volume":"74","author":"Misaka","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13105-013-0296-x","article-title":"Effect of simvastatin and naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: an in vivo and in vitro study","volume":"70","author":"Motawi","year":"2014","journal-title":"J. Physiol. Biochem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1080\/00498254.2017.1358469","article-title":"Honey flavonoids inhibit hOATP2B1 and hOATP1A2 transporters and hOATP-mediated rosuvastatin cell uptake in vitro","volume":"48","author":"Navratilova","year":"2018","journal-title":"Xenobiotica"},{"key":"B47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11745-006-3008-2","article-title":"Absorption of dietary cholesterol oxidation products and their downstream metabolic effects are reduced by dietary apple polyphenols","volume":"42","author":"Ogino","year":"2007","journal-title":"Lipids"},{"key":"B48","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"","journal-title":"J. Clin. Epidemiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"","journal-title":"J. Clin. Epidemiol."},{"key":"B50","first-page":"291","article-title":"Effect of food on pravastatin pharmacokinetics and pharmacodynamics","volume":"31","author":"Pan","year":"1993","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/j.1552-4604.1995.tb04015.x","article-title":"Effect of food on the bioavailability of atorvastatin, an HMG-CoA reductase inhibitor","volume":"35","author":"Radulovic","year":"1995","journal-title":"J. Clin. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"188","DOI":"10.18433\/j3ms5c","article-title":"Inhibitory effects of eight green tea catechins on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activities","volume":"19","author":"Satoh","year":"2016","journal-title":"J. Pharm. Pharm. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.molmet.2018.02.005","article-title":"Statin dose reduction with complementary diet therapy: a pilot study of personalized medicine","volume":"11","author":"Scolaro","year":"2018","journal-title":"Mol. Metab."},{"key":"B55","doi-asserted-by":"publisher","first-page":"758S","DOI":"10.1093\/jn\/129.3.758S","article-title":"Dietary isoflavones: biological effects and relevance to human health","volume":"129","author":"Setchell","year":"1999","journal-title":"J. Nutr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1002\/jps.22586","article-title":"Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and\/or P-glycoprotein","volume":"100","author":"Shirasaka","year":"","journal-title":"J. Pharm. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2133\/dmpk.dmpk-10-rg-073","article-title":"Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein\/multidrug resistance 1","volume":"26","author":"Shirasaka","year":"","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pharmthera.2006.03.003","article-title":"Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions","volume":"112","author":"Shitara","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/0163-7258(93)90031-8","article-title":"Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors","volume":"60","author":"Sirtori","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","article-title":"The pharmacology of statins","volume":"88","author":"Sirtori","year":"2014","journal-title":"Pharmacol. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"375S","DOI":"10.1093\/ajh\/6.11.375S","article-title":"Pharmacokinetics of fluvastatin and specific drug interactions","volume":"6","author":"Smith","year":"1993","journal-title":"Am. J. Hypertens."},{"key":"B62","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1271\/bbb.68.428","article-title":"Isoflavones inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase in vitro","volume":"68","author":"Sung","year":"2004","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1080\/00498254.2021.1969480","article-title":"In vitro and in vivo evaluation of organic anion-transporting polypeptide 2B1-mediated pharmacokinetic interactions by apple polyphenols","volume":"51","author":"Takahashi","year":"2021","journal-title":"Xenobiotica"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/s0024-3205(99)00380-x","article-title":"In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin","volume":"65","author":"Ubeaud","year":"1999","journal-title":"Life Sci."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.17605\/OSF.IO\/DJW5G","article-title":"Drug-food interactions of cholesterol-lowering statins and polyphenols-based dietary supplements: friends or foes?","author":"Viana","year":"2024","journal-title":"OSF Regist"},{"key":"B66","doi-asserted-by":"publisher","first-page":"E455","DOI":"10.1210\/jc.2012-3387","article-title":"Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells","volume":"98","author":"Villanueva","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/antiox11061212","article-title":"Dietary polyphenol, gut microbiota, and health benefits","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/13880209.2015.1034326","article-title":"Identification of natural products as modulators of OATP2B1 using LC-MS\/MS to quantify OATP-mediated uptake","volume":"54","author":"Wen","year":"2016","journal-title":"Pharm. Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.jacc.2013.02.058","article-title":"The P-glycoprotein transport system and cardiovascular drugs","volume":"61","author":"Wessler","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American heart association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.fertnstert.2011.08.010","article-title":"Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells","volume":"96","author":"Wong","year":"2011","journal-title":"Fertil. Steril."},{"key":"B72","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1365-2125.2011.04150.x","article-title":"Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment","volume":"73","author":"Wu","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/00498254.2016.1159747","article-title":"Epigallocatechin-3-gallate decreases the transport and metabolism of simvastatin in rats","volume":"47","author":"Yang","year":"2017","journal-title":"Xenobiotica"},{"key":"B74","doi-asserted-by":"publisher","first-page":"119975","DOI":"10.1016\/j.lfs.2021.119975","article-title":"Flavonoid-statin interactions causing myopathy and the possible significance of OATP transport, CYP450 metabolism and mevalonate synthesis","volume":"291","author":"Zechner","year":"2022","journal-title":"Life Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/chromsci\/bmy034","article-title":"Simultaneous determination of rosuvastatin, naringin and naringenin in rat plasma by RRLC-MS\/MS and its application to a pharmacokinetic drug interaction study","volume":"56","author":"Zeng","year":"2018","journal-title":"J. Chromatogr. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1541871\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T05:47:32Z","timestamp":1748584052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1541871\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":75,"alternative-id":["10.3389\/fphar.2025.1541871"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1541871","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"article-number":"1541871"}}